These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 153768)
1. Chemistry of heparitin sulfate and heparin from normal tissues and from patients with Hunter syndrome. Nader HB; Cohen DM; Dietrich CP Biochim Biophys Acta; 1979 Jan; 582(1):33-43. PubMed ID: 153768 [TBL] [Abstract][Full Text] [Related]
2. On the structure of heparitin sulfates. Analyses of the products formed from heparitin sulfates by two heparitinases and a heparinase from Flavobacterium heparinum. Silva M; Dietrich CP; Nader HB Biochim Biophys Acta; 1976 Jun; 437(1):129-41. PubMed ID: 132967 [TBL] [Abstract][Full Text] [Related]
3. Structural differences of heparan sulfates according to the tissue and species of origin. Dietrich CP; Nader HB; Straus AH Biochem Biophys Res Commun; 1983 Mar; 111(3):865-71. PubMed ID: 6220714 [TBL] [Abstract][Full Text] [Related]
4. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695 [TBL] [Abstract][Full Text] [Related]
5. Identification of N-sulphated disaccharide units in heparin-like polysaccharides. Jacobsson I; Höök M; Pettersson I; Lindahl U; Larm O; Wirén E; von Figura K Biochem J; 1979 Apr; 179(1):77-87. PubMed ID: 157737 [TBL] [Abstract][Full Text] [Related]
6. Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. Dietrich CP; Tersariol IL; Toma L; Moraes CT; Porcionatto MA; Oliveira FW; Nader HB Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):417-29. PubMed ID: 9620437 [TBL] [Abstract][Full Text] [Related]
7. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Hallak LK; Collins PL; Knudson W; Peeples ME Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881 [TBL] [Abstract][Full Text] [Related]
8. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes. Toma L; Dietrich CP; Nader HB Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472 [TBL] [Abstract][Full Text] [Related]
9. Specificity studies on the heparin lyases from Flavobacterium heparinum. Desai UR; Wang HM; Linhardt RJ Biochemistry; 1993 Aug; 32(32):8140-5. PubMed ID: 8347612 [TBL] [Abstract][Full Text] [Related]
10. Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. Nader HB; Buonassisi V; Colburn P; Dietrich CP J Cell Physiol; 1989 Aug; 140(2):305-10. PubMed ID: 2745565 [TBL] [Abstract][Full Text] [Related]
12. The distribution of sulfated uronic acid and hexosamine residues in heparin and heparan sulfate. Cifonelli JA; King J Connect Tissue Res; 1975; 3(1):97-104. PubMed ID: 126132 [TBL] [Abstract][Full Text] [Related]
13. Microanalysis of glycosaminoglycan-derived disaccharides labeled with the fluorophore 2-aminoacridone by capillary electrophoresis and high-performance liquid chromatography. Kitagawa H; Kinoshita A; Sugahara K Anal Biochem; 1995 Nov; 232(1):114-21. PubMed ID: 8600818 [TBL] [Abstract][Full Text] [Related]
14. Minimum fragments of the heparin molecule able to produce the accumulation and change of the sulfation pattern of an antithrombotic heparan sulfate from endothelial cells. Pinhal MA; Santos IA; Silva IF; Dietrich CP; Nader HB Thromb Haemost; 1995 Oct; 74(4):1169-74. PubMed ID: 8560430 [TBL] [Abstract][Full Text] [Related]
15. Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n. ten Dam GB; van de Westerlo EM; Smetsers TF; Willemse M; van Muijen GN; Merry CL; Gallagher JT; Kim YS; van Kuppevelt TH J Biol Chem; 2004 Sep; 279(37):38346-52. PubMed ID: 15247295 [TBL] [Abstract][Full Text] [Related]
16. Specificity of flavobacterial glycuronidases acting on disaccharides derived from glycosaminoglycans. Hovingh P; Linker A Biochem J; 1977 Aug; 165(2):287-93. PubMed ID: 921751 [TBL] [Abstract][Full Text] [Related]
17. Disaccharide composition of heparan sulfates: brain, nervous tissue storage organelles, kidney, and lung. Tekotte H; Engel M; Margolis RU; Margolis RK J Neurochem; 1994 Mar; 62(3):1126-30. PubMed ID: 8113800 [TBL] [Abstract][Full Text] [Related]
18. Heparinase II from Flavobacterium heparinum. Role of histidine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis. Shriver Z; Hu Y; Sasisekharan R J Biol Chem; 1998 Apr; 273(17):10160-7. PubMed ID: 9553064 [TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of heparinase that degrades both heparin and heparan sulfate from Bacillus circulans. Yoshida E; Sakai K; Tokuyama S; Miyazono H; Maruyama H; Morikawa K; Yoshida K; Tahara Y Biosci Biotechnol Biochem; 2002 May; 66(5):1181-4. PubMed ID: 12092842 [TBL] [Abstract][Full Text] [Related]
20. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. Nader HB; Porcionatto MA; Tersariol IL; Pinhal MA; Oliveira FW; Moraes CT; Dietrich CP J Biol Chem; 1990 Oct; 265(28):16807-13. PubMed ID: 2211596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]